Periodic Reporting for period 1 - REMIND EBOV (Role of the mucin-like domain of the Ebola virus in modulating virus-glycosaminoglycan interactions)
Reporting period: 2021-08-01 to 2023-07-31
In this project, fluorescent pseudotypes of the deadly filovirus Ebola were produced, using a lentiviral pseudotyping system with a mCherry-tagged viral core. A workflow for their in-depth characterization on a single particle level is proposed. Additionally, the particles were used in single particle kinetic assays, to test the hypothesis that mucin-like domain of Ebola, a highly glycosylated region of the protein, is important in modulating the attachment and detachment of the virus from the cell surface.
A thorough characterization of pseudotype properties and the production of more homogenous samples will strengthen the interpretations of experimental results within virology and also contribute to the optimization of pseudotype-based vaccines. In addition, understanding the mechanisms by which virus interactions at the cell surface are modulated, can help developing therapeutics for future outbreaks.
To assess the influence of the mucin-like domain of Ebola on the virus binding dynamics, a pseudotype virus containing a GP protein with this domain deleted was produced. A platform mimicking the carbohydrate layer covering the cells (glycocalyx) produced by end-immobilized heparan sulfate chains, was used to investigate the initial attachment behaviour of the virus. The results indicate that the deletion of the mucin-like domain, does not impact the attachment or detachment behaviour of the pseudotypes to heparan sulfate, in comparison to the wildtype GP.
The findings from this project were presented at several scientific conferences and seminars. A manuscript is currently under preparation and will be published in an open-access journal. In addition, the results and scripts generated in this project will be made available.